Articles by Disease (Hepatocellular Cancer)

The mTOR Signaling Pathway and mTOR Inhibitors in Cancer: Next-generation Inhibitors and Approaches

Journal: Current Molecular Medicine
Volume: 24
Page: 478-494
Author(s): Murat Ihlamur, Busra Akgul, Yağmur Zengin, Şenay Vural Korkut, Kübra Kelleci* and Emrah Şefik Abamor

The Therapeutic Effects of Withaferin A against Cancer: Overview and Updates

Journal: Current Molecular Medicine
Volume: 24
Page: 404-418
Author(s): Prathapan Abeesh and Chandrasekaran Guruvayoorappan*

Non-coding RNAs as Biomarkers for Survival in Colorectal Cancer Patients

Journal: Current Aging Science
Volume: 17
Page: 5-15
Author(s): Mohammad Qasim Andrabi, Yasodha Kesavan and Satish Ramalingam*

Traditional Uses, Phytochemistry, and Pharmacological Activities of Coleus amboinicus: A Comprehensive Review

Journal: Current Pharmaceutical Design
Volume: 30
Page: 519-535
Author(s): Karthika Paul*, Benachakal Honnegowda Jaswanth Gowda*, Umme Hani, Ravandur Shivanna Chandan, Sourav Mohanto, Mohammed Gulzar Ahmed, Sumel Ashique and Prashant Kesharwani

Interplay between LncRNA/miRNA and TGF-β Signaling in the Tumorigenesis of Gynecological Cancer

Journal: Current Pharmaceutical Design
Volume: 30
Page: 352-361
Author(s): Pegah Safavi, Kimia Behrouz Moghadam, Zahra Haghighi, Gordon A. Ferns and Farzad Rahmani*

Recent Updates on the Therapeutics Benefits, Clinical Trials, and Novel Delivery Systems of Chlorogenic Acid for the Management of Diseases with a Special Emphasis on Ulcerative Colitis

Journal: Current Pharmaceutical Design
Volume: 30
Page: 420-439
Author(s): Ranjit K. Harwansh*, Hemant Bhati and Rohitas Deshmukh

A Strategy based on Bioinformatics and Machine Learning Algorithms Reveals Potential Mechanisms of Shelian Capsule against Hepatocellular Carcinoma

Journal: Current Pharmaceutical Design
Volume: 30
Page: 377-405
Author(s): Xianqiang Zhou, Fang Tan, Suxian Zhang, An'an Wang* and Tiansong Zhang*